Related Experiment Video

Updated: Jul 17, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Role of postprandial hyperglycaemia in cardiovascular disease in diabetes

S-I Yamagishi1, K Nakamura, T Matsui

  • 1Department of Medicine, Division of Cardiovascular Medicine, Kurume University School of Medicine, Kurume, Japan. shoichi@med.kurume-u.ac.jp

International Journal of Clinical Practice
|January 19, 2007
PubMed

Insights

Diabetes significantly elevates atherosclerosis risk, with postprandial hyperglycemia being a key driver beyond traditional factors. Understanding these diabetes-specific mechanisms is crucial for developing targeted therapies to prevent cardiovascular disease (CVD).

Area of Science:

  • Endocrinology and Metabolism
  • Cardiovascular Research
  • Molecular Medicine

Background:

  • Diabetes mellitus markedly increases the risk of atherosclerotic vascular disorders, including coronary, cerebrovascular, and peripheral artery disease.
  • Cardiovascular disease (CVD) is a leading cause of disability and mortality in diabetic patients.
  • While conventional risk factors contribute, they do not fully explain the exaggerated CVD risk in diabetes.

Purpose of the Study:

  • To review the molecular mechanisms underlying accelerated atherosclerosis in diabetic patients.
  • To emphasize the role of postprandial hyperglycemia as a specific diabetes-related risk factor.
  • To discuss potential therapeutic strategies targeting CVD in diabetes.

Main Methods:

  • Literature review focusing on molecular mechanisms of atherosclerosis in diabetes.
  • Analysis of the contribution of postprandial hyperglycemia to cardiovascular complications.
  • Exploration of therapeutic targets for CVD in diabetic populations.

Main Results:

  • Accelerated atherosclerosis in diabetes involves specific mechanisms beyond traditional risk factors.
  • Postprandial hyperglycemia plays a significant role in enhancing this accelerated process.
  • Existing risk factors are insufficient to account for the full extent of macrovascular complications.

Conclusions:

  • Specific diabetes-related factors, particularly postprandial hyperglycemia, are critical contributors to the excess CVD risk.
  • Further research into these mechanisms is needed to develop effective, targeted therapies.
  • Novel therapeutic strategies focusing on diabetes-specific pathways are essential for managing CVD in diabetic patients.

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...